Multiple Sclerosis International Federation
My World of MS
online community		 | resize text | home |

National support About MS Get Involved Life with MS Research Resources News About MSIF  
 National support   About MS   Get Involved   Life with MS   Research   Resources   News   About MSIF 
 
News
Donate advanced search
print version print this page
 

inside
News:
Making Connections Newsletter
MSIF News
MS news
Leap of Faith for climbers with MS
Press room

 
  Oral FTY720 (Fingolimod) reduced relapse rate more effectively than Avonex in initial results of one-year study in relapsing-remitting MS
Initial results of a global study involving people with relapsing-remitting MS have been released.

To read about this study, as reported by the US National MS Society, click here.


Source: US National MS Society
Copyright &<br>Link Policy Copyright &
Link Policy 		Privacy Policy Privacy Policy back to top
Disclaimer Disclaimer Acknowledgements Acknowledgements
back to top  back to top  
Email Update Email Update Edit User Details Edit User Details Feedback Feedback Glossary Glossary Site Map Site Map
Back to top Back to top